Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.

Fiche publication


Date publication

novembre 2019

Journal

Lupus

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEVILLIERS Hervé


Tous les auteurs :
Jolly M, Annapureddy N, Arnaud L, Devilliers H

Résumé

To quantify changes in generic patient-reported outcomes against clinically meaningful, disease activity measures in systemic lupus erythematosus (SLE).

Mots clés

Systemic lupus erythematosus, minimally important difference, patient-reported outcomes

Référence

Lupus. 2019 Nov 1;:961203319886065